Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 8, 2014, Pages 1263-1265

  Pilmis, B ^a   Parize, P ^a   Zahar, J R ^a   Lortholary, O ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; CEFOXITIN; DORIPENEM; ERTAPENEM; IMIPENEM; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CEPHAMYCIN DERIVATIVE;

ADULT; ANTIMICROBIAL THERAPY; BACTEREMIA; BLOODSTREAM INFECTION; CHILD; CYSTITIS; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATITIS; PYELONEPHRITIS; RECURRENT INFECTION; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; MICROBIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEPSIS; URINARY TRACT INFECTIONS;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEPHAMYCINS; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SEPSIS; URINARY TRACT INFECTIONS;

EID: 84903818298     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2094-y     Document Type: Letter

References (11)

1. Zahar J-R, Bille E, Schnell D, Lanternier F, Mechai F, Masse Vet al (2009) Extension of beta-lactamases producing bacteria is a worldwide concern. Med Sci (Paris) 25:939-944. doi:10.1051/medsci/20092511939
2. Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois Vet al (2009) Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 63:1205-1214. doi:10.1093/jac/dkp108
3. Meier S, Weber R, Zbinden R, Ruef C, Hasse B (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39:333 - 340. doi:10.1007/s15010-011-0132-6
4. Hoban DJ, Nicolle LE, Hawser S, Bouchillon S, Badal R (2011) Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010. Diagn Microbiol Infect Dis 70:507 - 511. doi:10.1016/j.diagmicrobio.2011.03.021
5. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A et al (2000) Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30:473-478. doi:10.1086/313719 (Pubitemid 30205291)
6. Weldhagen GF, Poirel L, Nordmann P (2003) Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 47:2385-2392 (Pubitemid 36919434)
7. Pletz MWR, Rau M, Bulitta J, De Roux A, Burkhardt O, Kruse G et al (2004) Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob Agents Chemother 48:3765-3772. doi:10.1128/AAC.48.10.3765-3772. 2004 (Pubitemid 39304601)
8. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M et al (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413-431. doi:10.1111/j.1469-0691.2012.03821.x
9. Kim Y-K, Pai H, Lee H-J, Park S-E, Choi E-H, Kim J et al (2002) Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46:1481-1491 (Pubitemid 34415332)
10. Paterson DL (2000) Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 6:460-463
11. Lepeule R, Ruppé E, Le P, Massias L, Chau F, Nucci A et al (2012) Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β- lactamase. Antimicrob Agents Chemother 56:1376-1381. doi:10.1128/AAC.06233-11